Zobrazeno 1 - 2
of 2
pro vyhledávání: '"I Barral Juez"'
Autor:
MP Bachiller Cacho, MJ Iribar Sorazu, T Martin Valtierra, O Zarate Sesma, M Cancio Fanlo, JR Aginaga Badiola, A Aguillo Garcia, I Barral Juez, M Barral Juez, L Alba Coria, A Etxeberria Aguirre
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Polypharmacy and drug-related problems (DRP) increase the likelihood of negative health outcomes such as adverse reactions, interactions or lack of adherence. Moreover, published studies report DRPs as a frequent cause of hospitalisation a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0109352ba33655b894a65df8fbcb1e58
https://doi.org/10.1136/ejhpharm-2019-eahpconf.542
https://doi.org/10.1136/ejhpharm-2019-eahpconf.542
Autor:
Mauleon Echeverria, MJ Gayan Lera, P Carmona Oyaga, C Ripa Ciaurriz, M Umerez Igartua, P Pascual Gonzalez, I Aguirre Zubiay, C Sarasqueta Eizaguirre, M Ercilla Liceaga, I Barral Juez
Publikováno v:
European Journal of Hospital Pharmacy. 20:A148.3-A149
Background Etanercept is a soluble tumour necrosis factor receptor fusion protein used in a variety of arthropathies. A new administration device (pen) has recently been marketed. Purpose To evaluate pain differences and preference between the etaner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51ba082f0c35a9b464c28d4584138bc6
https://doi.org/10.1136/ejhpharm-2013-000276.411
https://doi.org/10.1136/ejhpharm-2013-000276.411